Myriad Genetics, Inc.’s MYGN Oncology growth strategy, which focuses on expanding companion diagnostics and market growth through new clinical guidelines, is poised to drive growth in the upcoming ...

Abramorama announced that it has acquired U.S. distribution rights to RadicalMedia’s production of Jake Sumner’s ...

Researchers successfully use a nonviral, piggyBac transposon system to introduce a transgene into cynomolgus monkeys.

Genetic engineering in non-human primates has long been limited by the need for virus-based gene delivery methods. Recently, ...

MeiraGTx's innovative gene therapies for ocular diseases & more are backed by strong clinical data and funding. Click here to find out why MGTX stock is a Buy.

Transgenic animals continue to play an essential role in many aspects of zebrafish research, including the development of disease models. The most widely used system for zebrafish transgenesis is the ...

Researchers at University of Tsukuba have developed a vector that integrates the Cre enzyme gene with the specific DNA ...

Researchers have engineered yeast to efficiently convert methanol into D-lactic acid, a key compound for biodegradable plastics and pharmaceuticals. By optimizing gene and promoter combinations, they ...

Using an unbiased approach, this important study discovered a role of Ezh2 in the differentiation of granule neuron precursors, the cell of origin for Shh group of medulloblastoma. Furthermore, the ...

EXCLUSIVE: After supplying the 2023 fall box office with $261M with his Taylor Swift: Eras Tour concert film, Sam Wrench is ...

Zandy Forbes’ biotech company MeiraGTx has developed targeted gene therapy methods to treat more than just genetic disorders. Now it’s on the cusp of its first regulatory approval. Each year ...

Shares plunged 26% after the disclosure, prompting Chairman Ashok Hinduja to affirm promoter support and capital adequacy above 15%, despite market concerns over the financial impact. IndusInd Bank ...